Solution
Industries
Resources
About
Beacon Search

NANOPASS

Company Snapshot

Founded: 2000
Entity Type: Private
Region: Israel
Headquarter: Nes Ziona, Israel
Key Geographics: Israel
Corporate Address: 3 Golda Meir Street Nes Ziona Israel Tel. +972-8-9462905 www.nanopass.com

Company Overview

NanoPass develops intradermal delivery solutions for vaccines and drugs. The company’s flagship product is the MicronJet microneedle device, which is FDA- and CE-cleared. This product is commercialized in Israel, Korea, China, Brazil, Hong Kong, and Russia.

The company seeks to enhance its global presence by collaborating with pharmaceutical companies and distributors to improve patient care worldwide. Additionally, the company boasts strategic partnerships and venture capitalist support and holds ISO 13485 certification.

NANOPASS In Reports

Global Microneedle Market

BCC Research Market Report says global market for microneedles is expected to grow from $1.0 billion in 2023 to $1.3 billion by the end of 2028, at a CAGR of 5.1%.

Global Markets for Insulin Drug and Delivery Technologies

BCC Research Market Report for Insulin Drug Delivery Devices. Global Markets for Insulin Drug and Delivery Technologies market trends, with market revenue and CAGRs through 2027.

Global Microneedle Market

BCC Research Market Report says microneedles should grow from $1.4 billion in 2021 to $1.7 billion by 2026 with a compound annual growth rate (CAGR) of 3.9%.

View All Reports

NANOPASS In News

MicronJet™ Continues Its Journey to Become the Gold Standard in Intradermal Delivery - PR Newswire

PR Newswire - Nov 26, 2025

NanoPass Brings Minimally Invasive MicronJet to Mexico - Mexico Business News

Mexico Business News - Nov 28, 2025

NanoPass partners with Korean company to manufacture microneedles - The Jerusalem Post

The Jerusalem Post - Dec 26, 2021

NanoPass Technologies Secures Awz Ventures' $4M Investment, Signaling Growth and Innovation in Intradermal Delivery Technology - PR Newswire

PR Newswire - Jul 15, 2024

Read All News

Company's Business Segments

  • Intradermal Delivery Solutions : The company offers painless intradermal delivery solutions for vaccines and drugs.

Applications/End User Industries

  • Aesthetic Treatments
  • Therapeutics
  • Cosmetics
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment